Read + Share
Herzog Tzarfati K, Gutwein O, Apel A, Rahimi-Levene N, et al. BNT162b2 COVID-19 vaccine is significantly less effective in patients with
hematologic malignancies. Am J Hematol 2021;96:1195-1203.
PMID: 34185336
|
 |
|
Herzog Tzarfati K, Gutwein O, Apel A, Rahimi-Levene N, et al. BNT162b2 COVID-19 vaccine is significantly less effective in patients with
hematologic malignancies. Am J Hematol 2021;96:1195-1203.
PMID: 34185336
|
|
|
|